JP2007501209A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501209A5
JP2007501209A5 JP2006522399A JP2006522399A JP2007501209A5 JP 2007501209 A5 JP2007501209 A5 JP 2007501209A5 JP 2006522399 A JP2006522399 A JP 2006522399A JP 2006522399 A JP2006522399 A JP 2006522399A JP 2007501209 A5 JP2007501209 A5 JP 2007501209A5
Authority
JP
Japan
Prior art keywords
compound
ion
carbonate
use according
stabilizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006522399A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007501209A (ja
Filing date
Publication date
Priority claimed from GBGB0318254.0A external-priority patent/GB0318254D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/003365 external-priority patent/WO2005013691A1/en
Publication of JP2007501209A publication Critical patent/JP2007501209A/ja
Publication of JP2007501209A5 publication Critical patent/JP2007501209A5/ja
Pending legal-status Critical Current

Links

Images

JP2006522399A 2003-08-04 2004-08-04 一酸化炭素の治療目的での放出のためのボラノカルボネートの使用 Pending JP2007501209A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0318254.0A GB0318254D0 (en) 2003-08-04 2003-08-04 Therapeutic delivery of carbon monoxide
GBGB0409376.1A GB0409376D0 (en) 2003-08-04 2004-04-27 Therapeutic delivery of carbon monoxide
PCT/GB2004/003365 WO2005013691A1 (en) 2003-08-04 2004-08-04 Use of boranocarbonates for the therapeutic delivery of carbon monoxide

Publications (2)

Publication Number Publication Date
JP2007501209A JP2007501209A (ja) 2007-01-25
JP2007501209A5 true JP2007501209A5 (https=) 2007-09-13

Family

ID=34137748

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522399A Pending JP2007501209A (ja) 2003-08-04 2004-08-04 一酸化炭素の治療目的での放出のためのボラノカルボネートの使用

Country Status (6)

Country Link
US (1) US20070065485A1 (https=)
EP (1) EP1675459A1 (https=)
JP (1) JP2007501209A (https=)
AU (1) AU2004262976A1 (https=)
CA (1) CA2534415A1 (https=)
WO (1) WO2005013691A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
GB2395432B (en) 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
DE102005047946A1 (de) * 2005-10-06 2007-05-03 Bayer Healthcare Ag Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Behandlung von akuten und chronischen Lungenkrankheiten
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
WO2008130261A1 (en) * 2007-04-24 2008-10-30 Alfama - Investigaçao E Desenvolvimento De Produtos Farmaceuticos Lda. Treatment of infections by carbon monoxide
DE102007026392A1 (de) * 2007-06-06 2008-12-11 Bayer Healthcare Ag Lösungen für die Perfusion und Konservierung von Organen und Geweben
ES2512066T3 (es) 2009-03-05 2014-10-23 The Uab Research Foundation Potenciación de la coagulación o reducción de la fibrinólisis
CA2792319A1 (en) 2010-03-08 2011-09-15 University Of Zuerich Carbon monoxide releasing rhenium compounds for medical use
US8927750B2 (en) 2011-02-04 2015-01-06 Universitaet Zu Koeln Acyloxy- and phosphoryloxy-butadiene-Fe(CO)3 complexes as enzyme-triggered co-releasing molecules
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
EP3129373B1 (en) * 2014-04-11 2021-09-01 Taipei Medical University Histone deacetylase inhibitors
DE102014008685A1 (de) * 2014-06-13 2015-12-17 Lorenz Meinel Freisetzungssystem für therapeutisches Gas
WO2017007955A1 (en) 2015-07-07 2017-01-12 The Research Foundation For The State University Of New York Use of amine carboxyboranes as therapeutic delivery of carbon monoxide and as general drug delivery system in the presence of reactive oxygen species
EP3524290A1 (en) 2018-02-09 2019-08-14 Julius-Maximilians-Universitaet Wuerzburg Method and system for monitoring carbon monoxide (co) administration to ex-vivo fluids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980583A (en) * 1974-02-19 1976-09-14 Mobil Oil Corporation Complexed metals bonded to inorganic oxides
US4322411A (en) * 1980-04-25 1982-03-30 Burroughs Wellcome Co. Anti-inflammatory nucleosides
JPH0670025B2 (ja) * 1987-08-07 1994-09-07 鐘紡株式会社 ベンゾチアゾ−ル誘導体および該化合物を有効成分とする抗リウマチ剤
US5362732A (en) * 1989-12-20 1994-11-08 University Of North Carolina At Chapel Hill Boronated compounds
WO1993005795A1 (en) * 1991-09-13 1993-04-01 Boron Biologicals, Inc. Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
FR2707085B1 (fr) * 1993-06-30 1995-08-18 Adir Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US7053242B1 (en) * 1999-10-05 2006-05-30 Mallinckrodt Inc. Carbon monoxide source for preparation of transition-metal-carbonyl-complexes
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
JP2005532351A (ja) * 2002-06-05 2005-10-27 イエール ユニバーシティ 血管形成、腫瘍増殖、および転移を治療する方法
GB0601394D0 (en) * 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
GB0613362D0 (en) * 2006-07-05 2006-08-16 Hemocorm Ltd Therapeutic delivery of carbon monoxide
WO2008130261A1 (en) * 2007-04-24 2008-10-30 Alfama - Investigaçao E Desenvolvimento De Produtos Farmaceuticos Lda. Treatment of infections by carbon monoxide
JP5563452B2 (ja) * 2007-07-24 2014-07-30 アルファーマ−インベスティガシオ エ デセンボルビメント デ プロデュトス ファルマセウティコス エレデア． 一酸化炭素による胃潰瘍の予防

Similar Documents

Publication Publication Date Title
JP2007501209A5 (https=)
JP2021063088A5 (https=)
EP0735859B1 (en) A pharmaceutical composition for the intranasal administration of hydroxocobalamin
JP2005526107A5 (https=)
TWI316942B (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
TW200817343A (en) Method of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
CN1306423A (zh) 用于治疗由一氧化氮源治疗用药引起的副作用的一氧化氮清除剂
JP2006523216A5 (https=)
CN1223347C (zh) 注射用西洛他唑水性制剂
ES2566973T3 (es) Uso de SNS-595 para tratar leucemia
EP2627641B1 (en) REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK USING NOVEL CUCURBIT[n]URIL MOLECULAR CONTAINERS
JP2005515202A (ja) プラチナ誘導体の薬学的調合物
JP2002525329A5 (https=)
ES3000668T3 (en) Acyclic cucurbit(n)uril type molecular containers to treat intoxication and decrease relapse rate in substance abuse disorders
JP2019515908A5 (https=)
JP2003532640A5 (https=)
JP2004517098A5 (https=)
US11291681B2 (en) Method for treating fibrotic liver tissue using Cl-IB-MECA
JP2026001066A (ja) 呼吸不全等による低酸素状態の対象を処置することに用いる医薬組成物
JP2005526832A (ja) α−ケトアルカン酸エステルまたは−アミドおよび乳酸または乳酸塩を含有する医薬組成物
RU2008146217A (ru) Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование
WO2005039640A1 (en) Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
RU2007131435A (ru) Противоопухолевое средство
RU2010137337A (ru) Способы и композиции для лечения респираторных заболеваний
JPWO2021093839A5 (https=)